Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

DDLSS: Nicola Aceto "Circulating Tumor Cells"

Schedule of event:

13/01/2025, 15:00

More event dates:

For this event there are no more dates.

Host:

Sebastian Schölch, OE0605

Speaker:

Prof Nicola Aceto, Molecular Oncology at the ETH Zurich

Organizer:

DDLSS Comittee

Language:

english

Description:

Nicola Aceto is Full Professor of Molecular Oncology at the ETH Zurich. Prior to joining ETH, he has been Swiss National Science Foundation Assistant Professor of Oncology at the University of Basel. The Aceto lab contributed to key discoveries in the metastasis field, including investigations of the biology and vulnerabilities of circulating tumor cells and their clusters, some of which already translated into clinical trials for patients with metastatic breast cancer. Nicola completed his training at the Friedrich Miescher Institute (FMI) in Basel, Switzerland, at the Massachusetts General Hospital Cancer Center and Harvard Medical School, and at the Broad Institute of MIT and Harvard in Boston, USA. To date, Nicola received three ERC Grants (StG 2015, PoC 2018, CoG 2020) and numerous awards related to his work on circulating tumor cells, including the Swiss Science Prize Latsis for Groundbreaking Cancer Research, the EACR Translational Cancer Research Award, the Robert Wenner Award from the Swiss Cancer League and the Friedrich Miescher Award for Outstanding Achievements in Biochemistry. He is an inventor in several patent applications related to the diagnosis and treatment of cancer, advisor for several companies with an interest in liquid biopsy, and co-founder of an ETH Spinoff biotech company dedicated to the development of new cancer medicines.

Venue:

BioQuant - Lecture Hall

Download:

 back to overview
to top
powered by webEdition CMS